How many shares were issued under HUTCHMED’s 2015 Share Option Scheme?

HUTCHMED issued 7,500 ordinary shares of US$0.1 each under the 2015 Share Option Scheme during the period. This modest issuance reflects options being exercised while leaving a large balance still available for future grants or exercises.

What is the size of HUTCHMED’s 2026 Share Option Scheme blocklisting?

The 2026 HUTCHMED Share Option Scheme was increased by 43,616,756 ordinary shares of US$0.1 each. By the end of the period, all 43,616,756 shares remained not yet issued or allotted, indicating capacity for future option exercises or grants.

When were the HUTCHMED share option schemes originally admitted to listing?

The 2015 Share Option Scheme’s 23,130,970 ordinary shares were admitted on June 17, 2019, following a share subdivision. The 2026 scheme’s 43,616,756 ordinary shares were admitted on June 11, 2026 after adoption at the May 12, 2026 annual general meeting.

What types of securities are involved in HUTCHMED’s share option schemes?

Both the 2015 and 2026 HUTCHMED Share Option Schemes involve ordinary shares of US$0.1 each. These ordinary shares are reserved for issue upon option exercises, subject to the terms and conditions of each respective share option scheme.

HUTCHMED updates share option blocklisting balances

HUTCHMED (China) Limited filed a blocklisting six monthly return covering its share option schemes for the period from December 29, 2025 to June 28, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

HUTCHMED (China) Limited filed a blocklisting six monthly return covering its share option schemes for the period from December 29, 2025 to June 28, 2026. The company reports activity under both its 2015 and 2026 HUTCHMED Share Option Schemes.

Under the 2015 scheme, 7,500 ordinary shares of US$0.1 each were issued during the period, leaving 45,768,368 shares available but not yet issued or allotted at the period end. The 2026 scheme was increased by 43,616,756 ordinary shares, all of which remain unissued at the end of the period.

The filing also notes that a total of 872,335,120 ordinary shares of US$0.1 each were in issue at the end of the period, providing context for the scale of these share option arrangements.

Key Figures

2015 scheme prior balance: 45,775,868 ordinary shares 2026 scheme increase: 43,616,756 ordinary shares 2015 scheme issued in period: 7,500 ordinary shares +5 more

8 metrics

2015 scheme prior balance 45,775,868 ordinary shares Balance under 2015 Share Option Scheme from previous return

2026 scheme increase 43,616,756 ordinary shares Increase in 2026 Share Option Scheme since last return

2015 scheme issued in period 7,500 ordinary shares Securities issued/allotted under 2015 scheme during period

2015 scheme ending balance 45,768,368 ordinary shares Not yet issued/allotted at period end under 2015 scheme

2026 scheme ending balance 43,616,756 ordinary shares Not yet issued/allotted at period end under 2026 scheme

Total shares in issue 872,335,120 ordinary shares Total number of securities in issue at end of period

2015 scheme original listing 23,130,970 ordinary shares Originally listed for 2015 scheme on June 17, 2019

2026 scheme original listing 43,616,756 ordinary shares Originally listed for 2026 scheme on June 11, 2026

Key Terms

Blocklisting Six Monthly Return, Share Option Scheme, ordinary shares, annual general meeting, +1 more

5 terms

Blocklisting Six Monthly Return regulatory

"HUTCHMED (China) Limited announces the following blocklisting six monthly return"

ordinary shares financial

"ordinary shares of US$0.1 each admitted on June 17, 2019"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

annual general meeting regulatory

"adopted at the annual general meeting held on May 12, 2026"

block admission scheme regulatory

"to replace the Company’s previous block admission scheme"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HUTCHMED (HCM) report in this blocklisting six monthly return?

HUTCHMED reports share movements under its 2015 and 2026 Share Option Schemes for the period from December 29, 2025 to June 28, 2026. It discloses new blocklisted shares, shares issued, and remaining shares available under each scheme.

How many HUTCHMED shares were in issue at the end of the period?

At the end of the period, HUTCHMED had 872,335,120 ordinary shares of US$0.1 each in issue. This figure provides overall equity context relative to the share option scheme balances and the potential future issuance under those schemes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/29/2026 - 06:12 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the Month of June 2026

Commission File Number: 001-37710

HUTCHMED (CHINA) LIMITED

(Translation of registrant’s name into English)

48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ⌧ Form 40-F ◻

HUTCHMED (CHINA) LIMITED

Form 6-K

EXHIBIT INDEX


Exhibit No.		Description

Exhibit 99.1		Announcement relating to blocklisting six monthly return

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	HUTCHMED (CHINA) LIMITED


	By:	/s/ Johnny Cheng
	Name:	Johnny Cheng
	Title:	Chief Financial Officer

Date: June 29, 2026

‌Exhibit 99.1

Blocklisting Six Monthly Return

Hong Kong, Shanghai, & Florham Park, NJ — Monday, June 29, 2026: HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM: HCM; HKEX: 13) announces the following blocklisting six monthly return:

1.	Name of applicant:	HUTCHMED (China) Limited
2.	Name of scheme:	(a) Share Option Scheme conditionally adopted by HUTCHMED in 2015 (“2015 HUTCHMED Share Option Scheme”) (b) Share Option Scheme adopted by HUTCHMED in 2026 (“2026 HUTCHMED Share Option Scheme”)

3.	Period of return:	From December 29, 2025 to June 28, 2026
4.	Balance under scheme from previous return:	(a) 2015 HUTCHMED Share Option Scheme: 45,775,868 ordinary shares of US$0.1 each (b) 2026 HUTCHMED Share Option Scheme: Nil

5.	The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:	(a) 2015 HUTCHMED Share Option Scheme: Nil (b) 2026 HUTCHMED Share Option Scheme: 43,616,756 ordinary shares of US$0.1 each

6.	Number of securities issued/allotted under scheme during period:	(a) 2015 HUTCHMED Share Option Scheme: 7,500 (b) 2026 HUTCHMED Share Option Scheme: Nil

7.	Balance under scheme not yet issued/allotted at end of the period:	(a) 2015 HUTCHMED Share Option Scheme: 45,768,368 ordinary shares of US$0.1 each (b) 2026 HUTCHMED Share Option Scheme: 43,616,756 ordinary shares of US$0.1 each

8.	Number and class of securities originally listed and the date of admission:	(a) 2015 HUTCHMED Share Option Scheme: 23,130,970 ordinary shares of US$0.1 each admitted on June 17, 2019 (to replace the Company’s previous block admission scheme following the Company’s share subdivision which took effect on May 30, 2019) (b) 2026 HUTCHMED Share Option Scheme: 43,616,756 ordinary shares of US$0.1 each admitted on June 11, 2026 following its adoption at the annual general meeting held on May 12, 2026




9.	Total number of securities in issue at the end of the period:	872,335,120 ordinary shares of US$0.1 each
Name of contact:		Weiguo Su / Johnny Cheng

Address of contact:

Level 18, The Metropolis Tower, 10 Metropolis Drive, Hung Hom, Kowloon, Hong Kong

Telephone number of contact:

+852 2121 8200

About HUTCHMED

HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception it has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved around the world including in the US, Europe and Japan. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.

CONTACTS


Investor Enquiries	+852 2121 8200 / ir@hutch-med.com

Media Enquiries
FTI Consulting –	+44 20 3727 1030 / HUTCHMED@fticonsulting.com
Ben Atwell / Tim Stamper	+44 7771 913 902 (Mobile) / +44 7779 436 698 (Mobile)
Brunswick – Zhou Yi	+852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com

Panmure Liberum	Nominated Advisor and Joint Broker
Atholl Tweedie / Emma Earl / Rupert Dearden	+44 20 7886 2500

Cavendish	Joint Broker
Geoff Nash / Nigel Birks	+44 20 7220 0500

Deutsche Numis	Joint Broker
Duncan Monteith / Ramin Naji	+44 20 7545 8000

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases

EX-99.1 EX-99.1 44.8 KB